Actual Medicinal Product (AMP) Nabumetone 500mg tablets (Medihealth (Northern) Ltd)
Stability Information
(Some stability information inherited from generic)
- Stability
-
Lack of data and/or stability concerns exist. MCA use may be acceptable but is likely to be off-label and require mitigation measures. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.
- Notes
-
Maximum 28 days in MCA. No stability data available but no theoretical concerns with product.
- Provenance
-
This recommendation is based on Nabumetone 500mg film-coated tablets (Tillomed Laboratries Ltd).
- Generic
- Nabumetone
- Formulation
- Nabumetone 500mg tablets
-
Nabumetone
-
Nabumetone 500mg tablets
-
Nabumetone 500mg tablets (Medihealth (Northern) Ltd)
-
-
Nabumetone 500mg dispersible tablets sugar free